Disclosed is a stabilizer for a lymph vessel, which comprises a Tie2 activator. Preferably, the Tie2 activator is at least one member selected from the group consisting of angiopoietin-1 (Ang-1), an extract from a plant belonging to the genus Cinnamomum, an extract from a plant Siberian ginseng, and syringaresionol.